In a previous report of 47 Chinese ANKL patients, 91.9% had a CD56bright/CD16dim- and CD57-negative phenotype (13).The CD56bright/CD16dim group could also represent an earlier stage of differentiation of either neoplastic or nonneoplastic NK cells (14). This evidence concerns the gene B3GAT1 and aggressive NK-cell leukemia.